Exercise Training for Aging
(STRRIDE IV Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must be on a stable dose of any cardiometabolic medications for at least one month to participate.
What data supports the effectiveness of the treatment High/Mod, High/Vig, Low/Mod in the clinical trial Exercise Training for Aging?
Research shows that regular exercise can slow down age-related declines in muscle and heart health, improve mobility, mental health, and quality of life, and help prevent or manage chronic diseases like heart disease and diabetes. Exercise is especially beneficial for older adults, including those who are frail, by enhancing physical function and independence.12345
Is exercise training safe for older adults?
How does the Exercise Training for Aging treatment differ from other treatments for aging-related conditions?
The Exercise Training for Aging treatment is unique because it combines different intensities of exercise, such as High/Mod, High/Vig, and Low/Mod, to specifically target age-related declines in muscle strength, endurance, and overall physical function. This approach is novel as it integrates both aerobic and resistance training, which are shown to improve muscle mass, strength, and reduce frailty in older adults, unlike standard treatments that may not address these multiple aspects of aging.711121314
What is the purpose of this trial?
The primary purpose of this study is to assess the effects of aging on markers of physical reserve and exercise-induced adaptations in resilience in older adults who completed a structured exercise program within the last 15 years (Parent trial: STRRIDE-PD; NCT00962962). This feasibility pilot study will enroll up to 8 participants to complete a 6-month aerobic exercise intervention.
Research Team
Leanna M Ross, PhD
Principal Investigator
Duke University
Eligibility Criteria
This trial is for adults who previously completed the STRRIDE-PD exercise program. Participants should have a BMI between 18 and 45 kg/m2 and be on a stable dose of any cardiometabolic medications for at least one month.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete a 6-month aerobic exercise intervention with varying intensities
Follow-up
Participants are monitored for changes in body composition, perceived global health, metabolic syndrome z-score, insulin sensitivity, and cardiorespiratory fitness
Treatment Details
Interventions
- High/Mod
- High/Vig
- Low/Mod
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
National Institutes of Health (NIH)
Collaborator